Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · IEX Real-Time Price · USD
5.98
-0.40 (-6.27%)
At close: May 17, 2024, 4:00 PM
6.05
+0.07 (1.17%)
After-hours: May 17, 2024, 7:39 PM EDT

Verve Therapeutics Market Cap

Verve Therapeutics has a market cap or net worth of $470.90 million as of May 17, 2024. Its market cap has decreased by -58.04% in one year.

Market Cap
470.90M
Enterprise Value
-76.79M
1-Year Change
-58.04%
Ranking
Category
Stock Price
$5.98

Market Cap Chart

Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $470.90M, a decrease of -45.83%. That is a compound annual growth rate of -18.95%.

History

DateMarket Cap% Change
May 17, 2024502.10M-6.27%
May 16, 2024535.70M2.41%
May 15, 2024523.10M-
May 14, 2024523.10M0.15%
May 13, 2024522.30M3.51%
May 10, 2024504.60M-5.51%
May 9, 2024534.00M4.60%
May 8, 2024510.50M-0.89%
May 7, 2024515.10M-3.90%
May 6, 2024536.00M-
May 3, 2024536.00M4.22%
May 2, 2024514.30M2.51%
May 1, 2024501.70M-0.18%
Apr 30, 2024502.60M-3.99%
Apr 29, 2024523.50M1.63%
Apr 26, 2024515.10M-0.96%
Apr 25, 2024520.10M-5.47%
Apr 24, 2024550.20M-4.36%
Apr 23, 2024575.30M-0.43%
Apr 22, 2024577.80M4.07%
Apr 19, 2024555.20M-0.31%
Apr 18, 2024556.90M-1.19%
Apr 17, 2024563.60M-5.59%
Apr 16, 2024597.00M-2.34%
Apr 15, 2024611.30M-3.81%
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Applied Therapeutics 502.77M
Larimar Therapeutics 502.11M
MaxCyte 498.67M
UroGen Pharma 497.87M
Editas Medicine 493.43M
Entrada Therapeutics 489.17M
Talkspace 488.69M
Nkarta 484.82M
Market Cap Rankings